Krystal Biotech, Inc. (KRYS)
358.05
-13.42
(-3.61%)
USD |
NASDAQ |
Sep 04, 16:00
358.05
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Cash and Short Term Investments (Annual) : 827.79M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 827.79M |
| December 31, 2024 | 597.52M |
| December 31, 2023 | 532.18M |
| December 31, 2022 | 379.17M |
| December 31, 2021 | 438.10M |
| Date | Value |
|---|---|
| December 31, 2020 | 271.26M |
| December 31, 2019 | 193.68M |
| December 31, 2018 | 111.76M |
| December 31, 2017 | 49.59M |
| December 31, 2016 | 1.923M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Marker Therapeutics, Inc. | 17.04M |
| TG Therapeutics, Inc. | 141.97M |
| Cytokinetics, Inc. | 885.34M |
| ADMA Biologics, Inc. | 87.63M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |